Sandy Coffta

Practice Management
Proposed Medicare rule will not improve radiology reimbursement
In a new column, Sandy Coffta of Healthcare Administrative Partners assesses how the 2022 Medicare Physician Fee Schedule Proposed Rule would affect radiology.
July 31, 2023
2023 07 31 22 22 6947 Medicare Puzzle Piece 400
Market Analysis
How you can help improve the Medicare Physician Fee Schedule
In a new column, Sandy Coffta of Healthcare Administrative Partners shares how radiologists can play their part in lobbying Congress to improve the Medicare Physician Fee Schedule.
June 12, 2023
2020 07 01 22 14 2802 Washington Dc Capitol 400
Practice Management
Last-minute Congressional action reduces Medicare fee cuts for 2023
In a new column, Sandy Coffta of Healthcare Administrative Partners (HAP) discusses the impact of the recent Congressional action to reduce the Medicare reimbursement pay cuts that had been scheduled to take effect in 2023.
January 8, 2023
2016 09 14 15 25 23 643 Dollar Sign 400
Practice Management
Regulatory update: Radiology faces revenue cuts in 2023
Unless Congress acts again at the last minute, Medicare reimbursement cuts will take effect in 2023. Sandy Coffta of Healthcare Administrative Partners assesses the situation in a new column.
December 4, 2022
2020 07 01 22 14 2802 Washington Dc Capitol 400
Practice Management
Expanded authorization for nonphysician providers
The American College of Radiology has recently revised its CT and MRI facility accreditation criteria to allow nonphysician providers (NPPs) to directly supervise contrast administration. Sandy Coffta of Healthcare Administrative Partners explains how it works.
November 6, 2022
2021 09 30 22 35 2834 Doctor Student Nurse Medical Personnel 400
Economics
The No Surprises Act final rule changes dispute resolution process
The final rule related to the No Surprises Act has made major changes to the independent dispute resolution process for resolving disputes over reimbursement. Sandy Coffta of Healthcare Administrative Partners explains how it works.
September 18, 2022
2019 11 13 00 46 2926 Business Deal Corporate 400
Practice Management
How will the MPFS proposed rule valuation changes impact radiology?
How will all the various changes in how Medicare and Medicaid calculate payment rates for medical services affect radiology? It's a complex question to answer, but Sandy Coffta of Healthcare Administrative Partners takes a crack at it in a new column.
August 14, 2022
2020 11 04 18 50 6655 Business Intelligence 400
Practice Management
What's in store for radiology in the 2023 Medicare Proposed Rule?
Who were the winners and who were the losers in the proposed 2023 Medicare Physician Fee Schedule (MPFS)? Sandy Coffta of Healthcare Administrative Partners deconstructs the MPFS and analyzes its potential impact on radiology.
July 20, 2022
2022 07 19 23 50 2007 Business Computer Investigation Magnifying Glass 400
PACS/VNA
Teleradiology agreements for today's radiology practice
The use of teleradiology services was originally framed around the need for a better lifestyle, usually to supplement a radiology group for its call obligation. Now is a good time for every radiology group to review their teleradiology service agreement, says Sandy Coffta of Healthcare Administrative Partners.
June 8, 2022
2020 09 10 22 26 0816 Computer City Connections 400
Economics
The contrast media shortage's impact on radiology
The shutdown of GE Healthcare's Shanghai, China, plant that began in April has caused a global shortage of the iodinated contrast media iohexol. Sandy Coffta of Healthcare Administrative Partners offers suggestions on how to cope.
June 1, 2022
2020 02 06 22 25 0448 Contrast Injector 400
Page 1 of 6
Next Page
Top Stories
Burden of PSMA-expressing prostate cancer before and after treatment with two cycles of Lu-177 PSMA-617. (A and B) Reduction in overall disease burden is evident after treatment. Avidity of patient’s primary prostate tumor and his osseous metastasis shown before (C) and after (D) treatment.
Molecular Imaging
Case report: Pluvicto as a first-line treatment in late-stage prostate cancer
Since 1996, the patient continually declined androgen deprivation therapy, chemotherapy, and local therapy to the prostate gland.
Mri Head
MRI
New brain MRI imaging technique could help identify Alzheimer's
Research Highlighter Res
Radiology Education
Scholarly activity low among residency program directors
Dexa
Digital X-Ray
3D DEXA shows value in patients with prostate cancer
Digital Innovations Shaping the Future of Radiology
Sponsor Content
Digital Innovations Shaping the Future of Radiology
More in Home
Case report: Pluvicto as a first-line treatment in late-stage prostate cancer
Since 1996, the patient continually declined androgen deprivation therapy, chemotherapy, and local therapy to the prostate gland.
September 26, 2025
Burden of PSMA-expressing prostate cancer before and after treatment with two cycles of Lu-177 PSMA-617. (A and B) Reduction in overall disease burden is evident after treatment. Avidity of patient’s primary prostate tumor and his osseous metastasis shown before (C) and after (D) treatment.
New brain MRI imaging technique could help identify Alzheimer's
By Kate Madden Yee
Researchers used 7-tesla MRI to demonstrate how microvessel pulses in the brain's deep white matter increase with age.
September 26, 2025
Mri Head
Scholarly activity low among residency program directors
By Amerigo Allegretto
Study results point toward program directors focusing on administrative responsibilities rather than scholarly activity.
September 26, 2025
Research Highlighter Res
3D DEXA shows value in patients with prostate cancer
By Will Morton
3D DEXA may be a practical and valuable tool for detecting structural bone changes in prostate cancer patients.
September 25, 2025
Dexa
Smith-Bindman unpacks NEJM pediatric CT study
By Kate Madden Yee
In a video interview, the researcher acknowledged CT's importance to patient care but advocated for its appropriate use.
September 25, 2025
Rebecca Smith-Bindman, MD
Women who skip first mammogram more likely to die of breast cancer
By Amerigo Allegretto
Women who do not participate in their first breast cancer screening are 40% more likely to die later from the disease.
September 24, 2025
Mammography Breast Ipad Patient 400
Study finds AI not cost-effective for breast cancer screening
By Amerigo Allegretto
AI is not cost-effective for breast cancer screening, even with reductions in mortality, false-positive cases, and false-negative cases, according to new research.
September 24, 2025
Breast Tomosynthesis Digital 400 (1)
ACS: Cancer survival rates are lower in rural areas
By Kate Madden Yee
The research also reported lower cancer survival rates for Blacks compared to whites, underscoring "disparities in receipt of care."
September 24, 2025
Rural Res
Save power, curb carbon by switching off surplus CT scanners
By Kate Madden Yee
A new study's findings suggest a relatively easy way to "go green" in the radiology suite.
September 23, 2025
Planet Sustainability
Radiologists deem AI x-ray reports clinically acceptable
By Will Morton
There was no evidence of a difference in acceptability between AI- and radiologist-generated reports under a standard criterion.
September 23, 2025
Kara Cxr
ACR CEO talks imaging’s role in spending bill
By Amerigo Allegretto
Dana Smetherman, MD, CEO of the ACR, spoke with AuntMinnie.com about appropriations bills and how imaging may be affected.
September 23, 2025
American Flag Waving 400 (1)
Adding MBI to DBT finds more breast cancers
By Amerigo Allegretto
Adding molecular breast imaging (MBI) to DBT screening leads to more invasive cancers detected in women with dense breasts.
September 23, 2025
Images in a 62-year-old woman who presented for screening. (A) Image from DBT screening (the synthesized 2D mediolateral oblique view of the left breast is shown) at year on was interpreted as negative and showing heterogeneously dense breast. (B) Image from molecular breast imaging screening (mediolateral oblique view) at year one reveals a 0.9-cm non-mass focal area of uptake in the left breast (arrow). (C) Targeted ultrasound scan (transverse image) shows a suspicious mass in the 3-o’clock position of the left breast, 4 cm from the nipple. Ultrasound-guided core biopsy and lumpectomy revealed a 0.9-cm grade 2 invasive ductal carcinoma, an estrogen receptor–negative, progesterone receptor–negative, human epidermal growth factor receptor 2–negative lesion, with two sentinel nodes negative (N0).
Page 1 of 173
Next Page